the well recognized untoward effects are tractable save for the definite augmentation of carcinogenesis , a measurable risk that is regarded as acceptable in treating rheumatoid arthritis with azathioprine and rheumatoid arteritis with cyclophosphamide .
C0003873
rheumatoid arthritis
C0004482
azathioprine